News

Blue light may contribute to headaches, but it's likely that other factors, like eye strain from staring at a screen for too ...
Scientists have decoded the atomic structure of Photosystem I from a 3-billion-year-old cyanobacteria lineage, offering a unique look at early oxygen-producing photosynthesis. The ancient nanodevice, ...
Blue Light Cystoscopy with Cysview utilizes a special scope and dye to detect and treat non muscle invasive bladder cancer.
Archaeopteryx is the fossil that proved Darwin right. It's the oldest known fossil bird, and it helps show that all birds— ...
PhotoCure ASA (PHCUF) reports robust revenue growth in Europe, while navigating significant sales declines in the US market.
Despite these gains, the revenue miss and a significant decline in US flexible cystoscopy kit sales contributed to a negative market reaction. Currently trading at $65.41, the stock has seen a modest ...
The company, which specializes in blue light cystoscopy (BLC) technology for bladder cancer diagnosis, reported modest financial improvements while advancing several strategic initiatives aimed at ...
The company continued to execute on its plan to expand blue light cystoscopy use in Q1 2025 with the installation of 21 new Saphira™ towers in the U.S. — 8 new accounts and 13 blue light tower ...
Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 125.3 million in the first quarter of 2025 (Q1 2024: NOK ...